EMA
approval
· 2025-05-23
EMA Authorised: Ifirmasta (previously Irbesartan Krka) (irbesartan hydrochloride) — Krka, d.d., Novo mesto
Summary
EMA has authorised Ifirmasta (irbesartan hydrochloride) by Krka for the treatment of hypertension. It is an authorised generic version of irbesartan hydrochlori…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Hypertension. MAH: Krka, d.d., Novo mesto. Decision date: 08/05/2025